Severe Drug Hypersensitivity Syndrome due to sulphasalazine in patient with rheumatoid arthritis;Grave sindrome da ipersensibilità a farmaci indotta da sulfasalazina in paziente con artrite reumatoide

Reumatismo

Volumn 61, Issue 1, 2009, Pages 65-68

  Gutierrez, Marwin ^a   Filippucci, E ^a   Bugatti, L ^b   Bertolazzi, C ^a   Grassi, W ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b A Murri Hospital   (Italy)

Author keywords

Drug Hypersensitivity Syndrome; Rheumatoid arthritis; Sulphasalazine

Indexed keywords

CREATINE; LIVER ENZYME; METHYLPREDNISOLONE; PREDNISONE; SALAZOSULFAPYRIDINE; ANTIINFLAMMATORY AGENT; ANTIRHEUMATIC AGENT; GLUCOCORTICOID;

ADULT; ARTICLE; CASE REPORT; CELL DEATH; CERVICAL LYMPHADENOPATHY; DISEASE SEVERITY; DOSE RESPONSE; DRESS SYNDROME; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; ERYTHEMA; EXTRAVASATION; FACE EDEMA; FEVER; GENERAL CONDITION IMPROVEMENT; HEPATOMEGALY; HUMAN; KERATINOCYTE; LYMPHOCYTIC INFILTRATION; MALE; MEDICAL EXAMINATION; REMISSION; RHEUMATOID ARTHRITIS; SKIN BIOPSY; SKIN MANIFESTATION; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; DRUG ERUPTION; DRUG HYPERSENSITIVITY; MIDDLE AGED; SYNDROME; TIME;

ANTI-INFLAMMATORY AGENTS; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DIAGNOSIS, DIFFERENTIAL; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; GLUCOCORTICOIDS; HUMANS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; REMISSION INDUCTION; SULFASALAZINE; SYNDROME; TIME FACTORS;

EID: 66149147966     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Vaillant L. Drug hypersensivity syndrome: drug rash with eosinophilia and systemic symptoms (DRESS). Jour Derm Treat 1999; 10: 267-72.
2. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994; 331: 1272-85.
3. Tas S, Simonart T. Drug rash with eosinophilia and systemic symptoms (DRESS syndrome). Acta Clin Belg 1999; 54: 197-200.
4. Tas S, Simonart T. Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update. Dermatology 2003; 206: 353-6.
5. Callot V, Roujeau JC, Bagot M, Wechsler J, Chosidow O, Souteyrand P, et al. Drug-induced pseudolymphoma and Hypersensitivity syndrome. Two different clinical entities. Arch Dermatol 1996; 132: 1315-21.
6. Bocquet H, Bagot M, Rojeau JC. DIDMOHS: A proposed consensus nomenclature for the drug-induced multiorgan hypersensivity syndrome. Arch Dermatol 1998; 134: 875.
7. Goldman J, Duval-Modeste AB, Musette P, Joly P, Massy N, Courville C, et al. Drug-induced hypersensitivity syndrome due to gabapentin. Ann Dermatol Venereol 2008; 135: 230-2.
8. Pernicova I, Middleton ET, Aye M. Strontium ranelate and DRESS syndrome put into perspective. European Medicine Agency on the alert. Osteoporos Int 2008; 19: 1811-2.
9. Tohyama M, Yahata Y, Yasukawa M, Inagi R, Urano Y, Yamanishi K, et al. Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. Arch Dermatol 1998; 134: 1113-7.
10. Morimoto T, Sato T, Matsuoka A, Sakamoto T, Ohta K, Ando T, et al. Trimethoprim-sulfamethoxazole-induced hypersensitivity syndrome associated with reactivation of human herpesvirus-6. Intern Med 2006; 45: 101-5.
11. Watkinson G. Sulphasalazine: a review of 40 years' experience. Drugs 1986; 32: 1-11.
12. Teo L, Tan E. Sulphasalazine-induced DRESS. Singapore Med J 2006; 47: 237-9.
13. MacDermott RP, Schloemann SR, Bertovich MJ, Nash GS, Peters M, Stenson WF. Inhibition of antibody secretion by 5-aminosalicylic acid. Gastroenterology 1989; 96: 442-8.
14. Danis VA, Franic GM, Rathjen DA, Laurent RM, Brooks PM. Circulating cytokine levels in patients with rheumatoid arthritis: results of a double blind trial with sulphasalazine. Ann Rheum Dis 1992; 51: 946-50.
15. Chopra S, Levell NJ, Cowley G, Gilkes JJ. Systemic corticosteroids in the phenytoin hypersensitivity syndrome. Br J Dermatol 1996; 134: 1109-12.
16. Roujeau JC. Treatment of severe drug eruptions. J Dermatol 1999; 26: 718-22.
17. Rieder MJ, Krause R, Bird IA, Dekaban GA. Toxicity of sulfonamide-reactive metabolites in HIV-infected, HTLV-infected, and noninfected cells. J Acquir Immune Defic Syndr Hum Retrovirol 1995;8:134-40.
18. Mostella J, Pieroni R, Jones R, Finch CK. Anticonvulsant hypersensitivity syndrome: treatment with corticosteroids and intravenous immunoglobulin. South Med J 2004; 97: 319-21.